Some researchers have argued that anti-GAD65 Ab has no pathogenic roles in the development of CAs based on the following reasons [25–27]: (1) Anti-GAD65 Ab is nonspecific and found in T1DM and various neurological conditions, such as SPS. This evidence concerns the gene GAD2 and stiff-person syndrome.